Skip to main content
logo
Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
0.8600
-0.0026 (-0.30%)
At close: Oct 30, 2026, 4:00 PM EST
0.8600
0.00 (0.00%)
Pre-market: Nov 2, 2026, 4:00 AM EST

Phio Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
-8.53-4.62-3.64-6.33-7.01-8.89
Operating Income
-13.47-9.22-7.39-10.7-11.46-13.51
Net Income
-12.9-8.7-7.15-10.83-11.48-13.29
Earnings Per Share
-1.36-1.45-9.08-46.76-90.91-111.87
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1321.035.388.4911.7824.06
Total Debt
---0.040.170.3
Net Cash (Debt)
1321.035.388.4611.6123.76
Net Cash Growth
20.61%290.77%-36.34%-27.18%-51.14%74.69%
Net Cash Per Share
1.373.516.8336.5291.94200.01

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.2-7.98-7.11-10.75-12.13-11.86
Capital Expenditures
-0.01-0.01-0-0.01-0.12-0.05
Free Cash Flow
-12.21-7.99-7.11-10.75-12.25-11.91
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-0.430.130.210.372.19
PS Ratio
------